Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
NCT00443612
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Irbesartan/Hydrochlorothiazide
DRUG:
Irbesartan
Sponsor
Sanofi